Gen İlaç (GENIL) %1400 Free Capital Increase Process

Gen İlaç (GENIL) %1400 Capital Increase Process

Gen İlaç (GENIL) announced its plan to increase its capital by %1400, raising it from 300 million TL to 4.5 billion TL. The process of free capital increase presents an important opportunity for all investors. Investors holding GENIL shares can benefit from this process until the split date, which will occur on February 10, 2026.

Benefiting from Free Capital Increase

Investors will have more lots after the increase in their shares. For example, an investor with 100 lots will have 1500 lots after the split. This increase will allow investors to expand their portfolios.

Share Price and Trading Conditions

After the free capital increase, the adjusted share price of GENIL has been set at 8.33 TL. The Capital Markets Board (SPK) approved Gen İlaç's application on January 29, 2026. All these developments are attracting investor attention and the impact on the stock market is eagerly awaited.

What Investors Need to Do

Investors with GENIL shares in their Midas investment account do not need to make any application for the free capital increase. The lots obtained from the split will automatically reflect in the investors' accounts, and the shares will start trading at the adjusted price. This stands out as a investor-friendly approach.

It should be noted that the information provided here does not constitute investment advice. It is important for investors to conduct their own research.